We are monitoring the impact of COVID-19 & Recession alarm on APAC Immunoassay Market Get in touch with us for detailed analysis Know More
Share on

Asia-Pacific Immunoassay Market Research Report – Segmented By Technology, Application, End Users, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1492
Pages: 132

APAC Immunoassay Market Size (2022 to 2027)

The size of the Immunoassay Market in the Asia Pacific was worth USD 4.37 Billion in 2022 and is estimated to reach USD 7.08 billion by the end of 2027, growing at a CAGR of 10.12% during the forecast period.  The Asia-pacific market is expected to show the highest growth over the forecast period due to the increasing development of new biologics, drugs, and vaccines.

The frequency of chronic illnesses has been rising in this region; as a result, diagnostic tests that give essential insights at every step of medical care, including prevention, detection, diagnosis, treatment, and successful management of health issues, are in high demand. The increase in point-of-care diagnostics with the rise in the advanced developments and technologies and the increase in the market for in-vitro diagnostics in Australia is anticipated to be driven by growing chronic illness occurrences.

To strengthen their market position, companies are boosting their R&D spending and regularly bringing integrated and closed systems to the market, which is expected to accelerate its growth rate. Additionally, due to economies of scale, outsourcing in instrumentation is rapidly replacing in-house instrumentation, owing to greater efficiency, speed, and reduced operational costs, which is expected to act favorably to the APAC immunoassays market.

As well as the increase in the market players with mergers and acquisitions, with new innovative ideas of product creation, are examples of competitive tactics. Also, an increase in the spreading awareness and importance regarding immunoassay among people can drive the market growth of the APAC immunoassay market.

However, the strict legal framework, a lack of adequate reimbursements as these processes are too tedious and consume lots of time; also due to the strict regulations make the process of the entry of the products complicated are the major restraints that are affecting the market growth of the immunoassay market in the APAC region. On the other hand, due to the increase in the new advancements in the immunoassay market, an increase in the market players like Roche Diagnostics, Beckman Coulter, Abbott Laboratories and may give rise to substitute products.

This research report on the Asia-Pacific Immunoassay Market has been segmented & sub-segmented the market into the following categories:

By Technology:

  • Enzyme Immunoassays
  • Fluorescent Immunoassays
  • Chemiluminescence Immunoassays
  • Nephelometric Immunoassays
  • Radio Immunoassays
  • Counting Immunoassays
  • Turbidimetric Immunoassays

By Application:

  • Oncology
  • Cancer
  • Hematology
  • Cardiology
  • Thyroid
  • Infectious diseases
  • Allergies

By End User:

  • Hospitals
  • Clinics
  • Academic Research Institute
  • Pharmaceutical
  • Biotech vendors
  • Laboratories

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Indian immunoassay market is expected to develop significantly over the next five years, owing to the rising prevalence of chronic and infectious illnesses in the nation. Furthermore, improvements in healthcare facilities and constant product improvements by major competitors in the market are some additional aspects that are expected to boost the market growth.  Additionally, through FY2027, the growing use of immunoassay-based point-of-care testing solutions in both home care and the hospital is projected to enhance the demand.

The Chinese immunoassay market is forecasted to be growing at a promising CAGR during the forecast period. Due to the increase in chronic illnesses such as cancer, diabetes, and cardiovascular disease are on the rise among China's aging population. Therefore, In- Vitro Diagnostics devices can be used to diagnose and monitor all of these illnesses.

The Japanese immunoassay market is another lucrative regional market in the APAC market. It is projected to showcase a healthy growth rate during the forecast period as Japan's population is increasingly aging and has a major geriatric population. Due to which in recent years, the healthy life expectancy has risen dramatically. Thus, it is projected to move the medical device industry's focus away from treatment and how it can be prevented.

The Australian immunoassay market is estimated to be growing at a moderate growth rate during the forecast period. In 2016, the Australian Institute of Health and Welfare estimated that the 3.7 million Australians that is the 15 percent of its population, were 65 or older. With the increase in the growing elderly population, age-related health issues may become more prevalent (arthritis, dementia, and cancer).

KEY MARKET PLAYERS:

Companies playing a prominent role in the Asia-Pacific immunoassay market analyzed in this report are Roche Diagnostics, DiaSorin S.p.A, Beckman Coulter, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Thermo Fisher Scientific and Abbott Laboratories, Akers Biosciences, Inc, Becton Dickinson and Company, Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe) and Intrinsic LifeSciences.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Technology                

                                5.1.1 Introduction           

                                5.1.2 Enzyme Immunoassay       

                                5.1.3 Fluorescent Immunoassays             

                                5.1.4 Cheniluminescence Immunoassays              

                                5.1.5 Nephelometric Immunoassays       

                                5.1.6 Radio Immunoassays         

                                5.1.7 Counting Immunoassays  

                                5.1.8 Counting Immunoassays  

                                5.1.9 Others      

                                5.1.10 Y-o-Y Growth Analysis, By Technology      

                                5.1.11 Market Attractiveness Analysis, By Technology     

                                5.1.12 Market Share Analysis, By Technology      

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Oncology 

                                5.2.3 Cancer      

                                5.2.4 Hematology           

                                5.2.5 Cardiology               

                                5.2.6 Thyroid     

                                5.2.7 Infectious disease

                                5.2.8 Allergies   

                                5.2.9 Others      

                                5.2.10 Y-o-Y Growth Analysis, By Application       

                                5.2.11 Market Attractiveness Analysis, By Application     

                                5.2.12 Market Share Analysis, By Application      

                5.3 End users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Academic research institutes          

                                5.3.5 Pharmaceutical and Biotech vendors           

                                5.3.6 Laboratories           

                                5.3.7 Others      

                                5.3.8 Y-o-Y Growth Analysis, By End users            

                                5.3.9 Market Attractiveness Analysis, By End users           

                                5.3.10 Market Share Analysis, By End users          

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Technology

                                                6.1.3.3 By Application

                                                6.1.3.4 By End users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Technology

                                                6.1.4.3 By Application

                                                6.1.4.4 By End users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technology

                                                6.1.5.3 By Application

                                                6.1.5.4 By End users

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Roche Diagnostics                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 DiaSorin S.p.A                           

                8.3 Beckman Coulter                     

                8.4 Siemens Healthcare                

                8.5 Ortho Clinical Diagnostics                     

                8.6 bioMerieux                

                8.7 Thermo Fisher Scientific                        

                8.8 Abbott Laboratories               

                8.9 Akers Biosciences                    

                8.10 Becton Dickinson and Company                      

                8.11 Devon Medical Products                    

                8.12 EDP Biotech Corporation                    

                8.13 Hologic                       

                8.14 Intrinsic LifeSciences                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Asia-Pacific Immunoassays Market, By Technology, From 2022 - 2027 (USD Billion)
  2. Asia-Pacific Enzyme Immunoassay Market, By Region, From 2022 - 2027 (USD Billion)
  3. Asia-Pacific Fluorescent Immunoassays Market, By Region, From 2022 - 2027 (USD Billion)
  4. Asia-Pacific Chemiluminescence Immunoassays Market, By Region, From 2022 - 2027 (USD Billion)
  5. Asia-Pacific Nephelometric Immunoassays Market, By Region, From 2022 - 2027 (USD Billion)
  6. Asia-Pacific Radio Immunoassays Market, By Region, From 2022 - 2027 (USD Billion)
  7. Asia-Pacific Counting Immunoassays Market, By Region, From 2022 - 2027 (USD Billion)
  8. Asia-Pacific Turbidimetric Immunoassays Market, By Region, From 2022 - 2027 (USD Billion)
  9. Asia-Pacific Immunoassays Market, By Application, From 2022 - 2027 (USD Billion)
  10. Asia-Pacific Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  11. Asia-Pacific Cancer Market, By Region, From 2022 - 2027 (USD Billion)
  12. Asia-Pacific Hematology Market, By Region, From 2022 - 2027 (USD Billion)
  13. Asia-Pacific Cardiology Market, By Region, From 2022 - 2027 (USD Billion)
  14. Asia-Pacific Thyroid Market, By Region, From 2022 - 2027 (USD Billion)
  15. Asia-Pacific Infectious diseases Market, By Region, From 2022 - 2027 (USD Billion)
  16. Asia-Pacific Allergies Market, By Region, From 2022 - 2027 (USD Billion)
  17. Asia-Pacific Immunoassays Market, By End users, From 2022 - 2027 (USD Billion)
  18. Asia-Pacific Hospitals Market, By Region, From 2022 - 2027 (USD Billion)
  19. Asia-Pacific Clinics Market, By Region, From 2022 - 2027 (USD Billion)
  20. Asia-Pacific Academic research institutes Market, By Region, From 2022 - 2027 (USD Billion)
  21. Asia-Pacific Pharmaceutical and biotech vendors Market, By Region, From 2022 - 2027 (USD Billion)
  22. Asia-Pacific laboratories Market, By Region, From 2022 - 2027 (USD Billion)
  23. Japan Immunoassays Market, By Technology, From 2022 - 2027 (USD Billion)
  24. Japan Immunoassays Market, By Application, From 2022 - 2027 (USD Billion)
  25. Japan Immunoassays Market, By End users, From 2022 - 2027 (USD Billion)
  26. China Immunoassays Market, By Technology, From 2022 - 2027 (USD Billion)
  27. China Immunoassays Market, By Application, From 2022 - 2027 (USD Billion)
  28. China Immunoassays Market, By End users, From 2022 - 2027 (USD Billion)
  29. India Immunoassays Market, By Technology, From 2022 - 2027 (USD Billion)
  30. India Immunoassays Market, By Application, From 2022 - 2027 (USD Billion)
  31. India Immunoassays Market, By End users, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample